Stay updated on Nivolumab in AML Prevention Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in AML Prevention Clinical Trial page.

Latest updates to the Nivolumab in AML Prevention Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision tag 'Revision: v3.4.2' was added, and the older 'Revision: v3.4.1' notice along with a government funding status notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA government funding status notice has been added and the revision is updated to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedGlossary is now shown by default. Added metadata fields include Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0; removed are the previously displayed (Estimated) indicators and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing v3.3.3, a minor update with no changes to study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section updated with new site listings across multiple states and Ontario. Page revision updated to v3.3.3.SummaryDifference2%

- Check71 days agoChange DetectedThe update timestamp label changes from 'Last Update Posted' to 'Last Update Posted (Estimated)'. This is a minor textual adjustment to the update information on the study details page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in AML Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Prevention Clinical Trial page.